9 9 8 VGI 36 5 21 9 −14 6 non-VGII 27 8 19 1 −8 8

9 9.8 VGI 36.5 21.9 −14.6 non-VGII 27.8 19.1 −8.8 selleck chemicals llc non-VGIII Selonsertib research buy 32.0 20.6 −11.4 non-VGIV VGI B8886 VGI 18.9 29.2 10.3 VGI 38.1 19.3 −18.8 non-VGII 26.7 16.4 −10.3 non-VGIII 32.3 17.9 −14.4 non-VGIV VGI B8887 VGI 15.9 28.3 12.4 VGI 23.6 15.5 −8.1 non-VGII 33.6 16.2 −17.4 non-VGIII 34.1 15.5 −18.7 non-VGIV VGI B8990 VGI 18.8 30.9 12.1 VGI 37.2 20.1 −17.1 non-VGII 31.3 16.9 −14.3 non-VGIII 40.0 19.3 −20.7 non-VGIV VGI B9009 VGI 21.6 31.0 9.4 VGI 36.5 23.1 −13.4 non-VGII 28.6 19.4 −9.2 non-VGIII 40.0 21.1 −18.9 non-VGIV VGI B4501 VGI 16.1 26.7 10.6 VGI 30.5 18.1 −12.4 non-VGII 30.6 17.3 −13.3 non-VGIII 29.4 16.4 −13.0 non-VGIV VGI B4503 VGI 15.9

27.2 11.2 VGI 32.7 18.6 −14.1 non-VGII 33.8 17.9 −15.9 non-VGIII 28.7 16.1 −12.6 non-VGIV VGI B4504 VGI 15.6 27.2 11.5 VGI 33.1 18.1 −15.1 non-VGII 33.9 17.4 −16.4 non-VGIII 28.7 15.8 −13.0 non-VGIV VGI B4516 VGI 15.3 26.8 11.5 VGI 31.5 17.6 −13.9 non-VGII 33.4 16.8 −16.6 non-VGIII 29.7 15.3 −14.3 non-VGIV VGI B5765 VGI 17.2 28.0 10.8

VGI 32.8 19.7 −13.0 non-VGII 34.4 19.2 −15.2 non-VGIII 29.0 16.3 −12.7 non-VGIV VGI B9018 VGI 17.7 30.0 12.3 VGI 34.6 17.9 −16.7 non-VGII 31.8 18.6 −13.2 non-VGIII 35.0 18.3 −16.8 non-VGIV VGI B9019 VGI 16.9 26.1 9.2 VGI 35.4 16.7 −18.7 non-VGII 34.9 16.7 −18.2 non-VGIII 30.5 16.8 −13.7 non-VGIV VGI B9021 VGI 21.4 32.9 11.5 VGI 33.4 19.9 −13.5 non-VGII 32.7 20.5 −12.2 non-VGIII 35.5 20.4 −15.2 non-VGIV VGI B9142 VGI 16.0 26.3 10.3 VGI 27.8 15.9 −11.9 non-VGII 32.7 16.5 −16.2 non-VGIII 31.7 16.6 −15.1 non-VGIV VGI B9149 VGI 17.7 26.8 9.1 VGI Flavopiridol (Alvocidib) 28.5 17.5 −11.0 non-VGII 28.5 18.2 −10.3 non-VGIII 31.0 18.3 −12.6 non-VGIV VGI B6864 VGIIa 27.8 17.5 −10.3 non-VGI Selleck mTOR inhibitor 19.3 33.1 13.8 VGII 34.7 19.7 −15.0 non-VGIII 40.0 16.1 −23.9 non-VGIV VGII B7395 VGIIa 28.9 18.8 −10.1

non-VGI 21.3 32.6 11.3 VGII 40.0 19.2 19.2 non-VGIII 40.0 18.8 −21.2 non-VGIV VGII B7422 VGIIa 27.4 17.4 −10.0 non-VGI 19.5 32.3 12.8 VGII 35.4 19.1 −16.3 non-VGIII 40.0 15.6 −24.4 non-VGIV VGII B7436 VGIIa 27.8 17.9 −9.9 non-VGI 20.7 35.4 14.7 VGII 36.5 16.9 −19.6 non-VGIII 40.0 15.6 −24.4 non-VGIV VGII B7467 VGIIa 30.9 20.7 −10.1 non-VGI 22.7 32.7 9.9 VGII 37.7 23.4 −14.2 non-VGIII 40.0 19.1 −20.9 non-VGIV VGII B8555 VGIIa 27.9 17.7 −10.2 non-VGI 19.7 32.1 12.4 VGII 34.6 20.8 −13.8 non-VGIII 40.0 16.6 −23.4 non-VGIV VGII B8577 VGIIa 31.1 20.9 −10.2 non-VGI 21.8 34.1 12.3 VGII 33.1 23.4 −9.8 non-VGIII 40.0 19.8 −20.2 non-VGIV VGII B8793 VGIIa 27.4 17.4 −10.0 non-VGI 18.9 32.6 13.7 VGII 39.0 24.9 −14.1 non-VGIII 40.0 16.3 −23.7 non-VGIV VGII B8849 VGIIa 28.9 18.7 −10.1 non-VGI 22.9 35.1 12.2 VGII 36.0 22.7 −13.3 non-VGIII 40.0 18.4 −21.6 non-VGIV VGII CA-1014 VGIIa 20.4 11.6 −8.8 non-VGI 13.6 32.4 18.9 VGII 31.1 12.8 −18.3 non-VGIII 40.0 11.0 −29.0 non-VGIV VGII CBS-7750 VGIIa 27.2 17.3 −9.9 non-VGI 18.8 33.1 14.3 VGII 38.0 25.5 −12.5 non-VGIII 40.0 15.8 −24.2 non-VGIV VGII ICB-107 VGIIa 28.1 18.2 −9.9 non-VGI 20.0 34.7 14.8 VGII 37.5 25.4 −12.1 non-VGIII 40.0 15.6 −24.4 non-VGIV VGII NIH-444 VGIIa 24.9 14.9 −10.0 non-VGI 17.

Comments are closed.